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Reduksjon av gassbobler i blodbanen: metoder for å forebygge ugunstige effekter av 
dekompresjon.  
 
Når en dykker returnerer til overflaten etter dykking, kan det dannes gassbobler i kroppen 
som følge av overmetning av gasser. Slike gassbobler kan igjen føre til trykkfallsyke, men det 
gjenstår fremdeles å finne alle mekanismene bak denne sammenhengen. Gassbobler er 
derimot gode indikatorer på risiko for trykkfallsyke, og den gjennomgående arbeidshypotesen 
i denne avhandlingen har vært at gassbobler i blodbanen er den bakenforliggende årsaken til 
alvorlig trykkfallsyke. Det å redusere mengden gassbobler vil dermed øke sikkerheten for 
dykkeren. 
 
Avhandlingen består av tre studier som på forskjellige måter forsøker å redusere 
boblemengden ved trykkreduksjon. Alle arbeidene er gjennomført med bruk av gris som 
forsøksdyr, og alle dykkene er simulert i trykk-kammer spesielt laget for slike studier. For å 
måle gassbobler har vi benyttet ultralydavbildning, samt at vi har tatt ut kar for å måle 
eventuelle funksjonelle endringer i disse i etterkant av dykkene.  
 
Den første studien demonstrer en ny metode for å redusere gassbobledannelsen ved 
dekompresjon. Ved kortvarig å øke trykket under pågående trykkreduksjon kan 
boblemengden signifikant reduseres, resultatene viser at en modell som tar hensyn til 
bobledannelse beskriver resultatene bedre enn en tradisjonell modell som bare tar hensyn til 
overmetningen. I den andre studien har vi for første gang vist at gassbobler i blodbanen kan 
påvirkes medikamentelt også hos store dyr under dekompresjon fra metning. Ved å gi nitrater 
umiddelbart før dekompresjonen startet, ble mengden gassbobler signifikant redusert 
sammenlignet med kontrollene som ikke fikk tilført nitrater. Studien åpner veien for videre 
studier av biokjemiske prosesser involvert i både dannelsen av og effektene av gassbobler. I 
den siste studien undersøkte vi om en behandlingsprosedyre for trykkfallsyke til bruk når et 
trykk-kammer ikke er tilgjengelig ville være effektiv om behandlingstrykket ble redusert fra 
190 kPa til 160 kPa med pusting av ren oksygen. Vi viste her at trykket var tilstrekkelig for å 
fjerne boblene etter dykket, men vi forhindret ikke skader på blodkarene.  
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ABBREVIATIONS AND DEFINITIONS 
 
ACh Acetylcholine 
ATA Atmosphere absolute 
BK Bradykinine 
CNS Central nervous system 
DCS Decompression sickness 
IWR In-water recompression 
kPa Kilopascal 
NO Nitric oxide 
SNP Sodium nitroprusside 
TEE Transesophaegal echocardiography 
 
Caisson work: Work in hyperbaric air atmosphere. 
  
Critical gradient: The largest difference in the surrounding pressure and internal pressure 
without formation of bubbles.  
 
Decompression: Refers to the process undertaken when moving from surroundings with 
higher pressures to surroundings with lower pressures.  
 
Saturation: In diving, this refers to the state where the body is at equilibrium where no more 
nitrogen can be absorbed, unless the partial pressure of the nitrogen in the breathing gas is 
increased. This form of diving is usually preferred when diving deeper than 50 meters of 
seawater.   
 
Supersaturation: In diving, this refers to a situation where the nitrogen pressure in the tissues 
exceeds the ambient pressure.  
 
Tissue tension: The level of any gas in a specific tissue.  
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INTRODUCTION 
 
Aims of the study 
 
The purpose of all decompression procedures is to prevent injury to the diver, and it is 
generally agreed that these injuries are caused by the formation of gas bubbles in the body. As 
gas bubbles are formed in nearly all decompressions, and the risk of developing 
decompression sickness (DCS) increases with the number of gas bubbles, the underlying 
hypothesis throughout this work has been that vascular gas bubbles are the main initiator of 
serious DCS. Hence, reducing the amount of gas bubbles will consequently increase the 
safety of the diver. The main objective was to:  
 
- Study the effect of changing decompression profiles on the amount of vascular gas 
bubbles 
- Study the effect of nitric oxide on bubble reduction in saturation decompression 
- Study the preventive effects of removing gas bubbles after a strenuous decompression 
by simulating in-water recompression with oxygen on functional changes caused by 
gas bubbles 
 
The activity of diving 
 
Diving is not only a worldwide popular leisure time activity, but also a professional activity 
both in several industries and in the military. Diving has distinct risks to health owing to its 
physical characteristics. Most health hazards in diving are the consequence of changes in gas 
volume and formation of gas bubbles due to reduction of ambient pressure during a diver’s 
ascent. Knowledge of the behaviour of any mixture of breathable gases under increased 
ambient pressure is crucial for safe diving and the understanding of the pathophysiology of 
compression or decompression related disorders.  
 
When diving, the ambient pressure increases with increasing depth underwater and the uptake 
of gas increases both with increasing depth and time at depth. Thus, to keep the lungs from 
collapsing, breathing gas must be supplied under high pressure. A diver breathing air is 
exposed to three different gases; nitrogen (N2), oxygen (O2) and carbon dioxide (CO2). Air 
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contains roughly 21% O2 and 79% N2.  While O2 is being metabolized, N2 is metabolically 
inert and is therefore not consumed. Any inert gas which is inspired under pressure will be 
absorbed, but each gas has different properties of solubility and diffusivity which will affect 
the uptake. The present thesis has focused on N2 as the inert gas. The exchange of dissolved 
inert gas between blood and tissue is controlled by blood flow and diffusion. Because of its 
inert nature, N2 remains dissolved until the N2 pressure in the lungs decreases, at which N2 is 
removed by the reverse respiratory process, a process which may take several hours [1]. 
Decompression procedures have been developed to prevent gas coming out of solution 
forming a gas phase, thus protecting the diver from developing gas bubbles upon surfacing. 
 
Decompression and bubbles  
 
Paul Bert demonstrated in 1887 that bubbles often were associated with symptoms of DCS 
[2]. The pathophysiology of DCS was studied throughout the latter part of the nineteenth 
century, but little work was done on how to prevent injury. Berts hypothesis that bubbles 
caused DCS was later central to Haldanes theory, and he argued that if bubbles could be 
avoided no DCS would occur [3]. Haldane observed caisson workers and discovered that they 
did not experience any symptoms of DCS after being decompressed from 2 ata (absolute 
atmosphere) to 1 ata. Based on his observation Haldane proposed that decompressions would 
be bubble free as long as the difference between the dissolved N2 tension in tissue and the 
absolute pressure, the supersaturation, did not exceed a critical value. We now know that 
bubble formation during decompression is not simply the consequence of inert gas 
supersaturation, as numerous experiments indicate that bubbles originate as pre-existing gas 
nuclei [4].  
 
A systematic study of the phenomena accompanying decompression is complex and difficult, 
as practical measurement methods to monitor the processes taking place in body tissue are 
lacking. Various mathematical models used to describe the decompression process reflect 
only a small part of the total phenomena [5]. However, the introduction of ultrasound, both 
Doppler and imaging, to detect vascular gas bubbles generated during and after a 
decompression, have made it possible to compare different decompression situations and 
models without the binominal endpoint DCS or no DCS. Bubbles detected in the vasculature 
do not necessarily lead to DCS, but their presence may be indicative of bubbles elsewhere in 
the body [6]. Gas bubbles, in the absence of clinical manifestations of DCS, have been 
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introduced as “silent bubbles”. However, incidents of DCS are generally accompanied by 
bubbles; hence, the risk of DCS appears to be increased [7] .  
 
Gas bubble formation 
 
If no dissolved gas is present, pure water will not form bubbles until the local pressure is 
reduced to about -1400 atm. This is known as de novo formation of bubbles and represents the 
tensile strength of water [8]. In a decompression situation, such pressure reduction is 
unrealistic, and in stead of de novo formation of bubbles one believes that the bubbles grow 
from some small, ever-existing nuclei containing gas [9].   
 
A bubble in a solution will grow or shrink by gas diffusion according to whether the solution 
is supersaturated or undersaturated. The internal pressure of a spherical gas bubble in a liquid 
depends on the bubble radius, the surface tension of the liquid and the external gas pressure as 
described by LaPlace’s law.  
 
Pbubble - pamb = 2γ/R + δ 
 
where Pbubble is the gas tension inside the bubble, pamb is the gas tension in the fluid 
surrounding the bubble, γ is the surface tension in the liquid-gas interface, R is the bubble 
radius and δ is additional deformation pressure opposing bubble expansion.  
 
It follows from the LaPlace equation that the pressure inside the bubbles is always greater 
than the surrounding pressure. The pressure difference, ∆P, results in an outward diffusion of 
gas, and the bubble will therefore shrink and finally dissolve. Surfactants in the liquid migrate 
to the bubble surface and reduce both γ and ∆P; thus stabilizing the bubble. The smaller the 
bubbles, the grater are their inner pressure. Thus, small bubbles dissolve more quickly then 
large bubbles.  
 
Gas embolism 
 
Intravascular gas bubbles occur in the venous system during most decompressions [10] [11], 
and are also known as vascular air embolism. Air embolisms are of great concern not only in 
activities involving decompression, but also in the operating room or other patient care 
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situations [12]. In the operation room, vascular air embolism is the entrainment of air (or 
exogenously delivered gas) from the operative field or other communication with the 
environment into the venous or arterial vasculature. There are two main categories of gas 
embolism, venous gas embolism (VGE) and arterial gas embolism (AGE). VGE and AGE 
are distinguished by different mechanism of gas entry and site where the emboli ultimately 
may lodge.  
 
Venous gas embolism 
 
Venous air embolism is the most frequent form of VGE, and may occur when gas enters the 
venous system [13]. The gas, if not trapped, will be transported along the venous system and 
enter the pulmonary arteries. The first microvessels encountered by venous bubbles are the 
pulmonary capillaries, and it has been demonstrated in vivo that bubbles, generated by 
decompression or being directly infused to the venous circulation, become trapped here [14]. 
Venous gas bubbles may also develop following laproscopy, by accidental injection or in 
cardiopulmonary bypass surgery [15] [16] [17]. Also, neurosurgery in the sitting position 
seem to predispose for VGE [18].  
  
Arterial gas embolism 
 
There are several possible pathways by which gas bubbles can enter the arterial circulation. 
The lung is considered to be a good filter for gas bubbles, but the lung may be damaged, 
resulting in bubbles travelling through the pulmonary vein and the left atrium. Gas bubbles 
may break through the lung filter if the lung is overloaded with gas [19] and enter the arterial 
circulation. In addition, venous gas bubbles may pass through a patent foramen ovale (PFO) 
or other extraordinary connections in the heart to reach the arterial circulation. The Foramen 
Ovale is functionally closed in the majority of the population, but it has been shown to be 
patent after foetal life in approximately 30% of humans [20]. The lung can also become 
overinflated during a rapid ascent, and in this case gas may escape directly into the pulmonary 
veins after alveolar rupture [21]. Arterial gas bubbles have been detected in divers after 
excursions [10], during decompression from saturation dives [22] and at autopsy after fatal 
accidents [23]. Arterial gas bubbles have also been observed in large animals during and after 
decompression [19] [24], and arterial shunting has been shown during exercise [25].  
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The pathophysiology of gas bubbles 
 
The sympthomatology of DCS is heterogeneous and not entirely explained by a mechanically 
mechanism. Distal symptoms are frequently seen, but several central organ systems, including 
the central nervous system (CNS) and the respiratory system, may be affected as well. It is 
quite possible that the pathogenesis of DCS, at least in part, may be of an inflammatory origin 
as there is a great  interindividual susceptibility to decompression trauma and furthermore, 
repetitive dives have resulted in greater tolerance to  DCS due to acclimatization [26] [27] 
[28] [29]. Bubbles may further evoke a tissue response with activation of platelets, the 
coagulation cascade [30] [31] [32], and complement [27].  
 
The pathological effects of bubbles may cause a mechanical disruption of the tissue 
concerned, for example the endothelium [33], with compression of non-compliant tissue or 
blood vessels and lymphatics, or from simply obstructing blood vessels.  
Signs and symptoms of DCS differ with the pressure profile and the breathing gas. 
Neurological symptoms are most common after short deep dives or altitude exposures with 
little or no preoxygenation. It is generally assumed that localized gas bubbles are responsible 
for all DCS incidents in the CNS. However, Wilmshurst and Bryson [34] showed that a large 
PFO can be found in about 50% of divers having central nervous symptoms. They have also 
observed that large shunts correlate well with spinal cord DCS. Wilmshurst [35] demonstrated 
further that there is a relationship between right-to-left shunts and cutaneous DCS, which 
often is associated with more serious DCS involving the CNS and the lung [36] [37]. Gas 
bubbles can cause changes in barrier permeability even in the absence of clinical 
manifestations of DCS. Breakdown of the blood-brain-barrier (BBB) and blood-lung-barrier 
(BLB) may allow proteins and leukocytes to move into the extra vascular brain tissue, with 
subsequent formation of oedema [38] [39] [40]. Leukocytes have been implicated in the 
progressive fall in cerebral blood flow and decreased cerebral function in animal models of 
gas embolism [41] [42]. Various plasma proteins including the coagulation system, 
complement and kinins are also activated by bubbles [43] [44].  
 
While bubbles in the venous system can explain pulmonary symptoms of DCS, there are other 
manifestations of DCS that can only be explained by bubble formation within the tissue 
themselves [45]. Extravascular bubbles may form in tissue that is aqueous or lipid, and except 
for extreme decompression, bubbles are seldom observed in heart, liver and skeletal muscle 
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[46]. Daniels [47] reported that the earliest bubbles detected were intravascular, but that 
substantial accumulation of stationary bubbles would occur before any signs of DCS. In the 
periphery of the body, small intravascular bubbles may grow into sufficient size to occlude 
small vessels and as such give rise to stationary intravascular bubbles. Blocking of the 
microcirculation causes not only tissue ischemia but also retards the elimination of dissolved 
gas and so produces local areas with gas tensions higher than the surrounding tissue [48]. 
Once formed, extravascular bubbles persist for long periods of time. Evidence of persistent 
gas bubbles up to two days after the original decompression has been shown [48].  
 
Endothelium 
 
The endothelium plays a key role in the short- and long-term regulation of the cardiovascular 
system and is the source of many factors that influence blood flow, blood coagulation as well 
as angiogenesis [49]. The vascular endothelium consists of a monolayer of cells lining the 
luminal surface of all blood vessels in the body (figure 1). The endothelium functions by 
sensing various physiologic stimuli and triggering release of multiple vasoactive substances, 
including nitric oxide (NO). Such physiologic stimuli can be both substances present in the 
blood or the shear stress associated with the blood flow. A large number of vasoactive 
substances are produced and secreted from endothelial cells to act on the underlying vascular 
smooth muscle cells. The balance between dilating and contracting factors is critical for 
maintaining vascular homeostasis [50].  
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Figure 1. The structure of the blood vessel wall with the three layers intima, media and adventitia. The figure is 
reproduced in agreement to conditions given by Stijn A. I. Ghesquiere, http://creativecommons.org/licenses/by-
sa/2.5/.  
 
The essential role of the endothelium in vasodilatation was found by coincidence by 
Furchgott and Zawadzki [51]. They discovered when rubbing the intimal surface of a rabbit 
aorta the vasodilating effect of Acetylcholine (ACh) decreased compared to unrubbed strips 
of aorta. But, the rubbing had no effect on the vasoconstricting agents, and rubbing of the 
adventitial surface of the strip had no effect on the response to ACh, suggesting the response 
observed was selectively endotheliumderived involving vasodilation of vascular smooth 
muscle cells.  
 
During resting conditions, the endothelial cells lining the blood vessels is a relatively inert 
surface that regulates and secures unhindered flow of cellular elements through the capillary 
beds. In response to an inflammatory signal initiated by bubbles, endothelial cells may be 
converted from an inactivated to an activated state resulting in cellular functional changes. 
These changes may in turn “un-stabilise” pre-existing nuclei and make them grow into 
bubbles. Activation of the endothelium generates endothelial microparticles (EMP), which are 
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fragments of activated endothelial cells. These may in turn reduce the endothelial function, 
possibly by increasing expression of the endothelial adhesion molecules such as vascular cell 
adhesion molecule-1 (VCAM-1), intracellular adhesion molecule-1 (ICAM-1) and E-selectin, 
and by influencing NO production [52] [53]. Following a decompression, this activation could 
be caused by endothelial damage from gas bubbles. The pathway is not exclusive for 
decompression-related bubbles, as endothelial activation has been observed in a number of 
cardiovascular diseases and from using heart-lung-machines [54]. In endothelial dysfunction, 
ACh fails to induce normal relaxation, and may in fact induce a paradoxical vasoconstriction 
by binding of cholinergic receptors on the smooth muscle cell surface. Thus, endothelial 
function is linked to cardiovascular health.  
 
Nitric oxide 
 
When stimulated by substances present in the blood, or by shear stress associated with blood-
flow, endothelial cells can release both constricting and dilating substances. NO is the most 
important vasodilator released by endothelial cells [55]. The function of the endothelium has 
been a major research area in the modern understanding of the circulatory system ever since 
the identification of endothelium-derived relaxing factor, which is a key mediator of 
vasodilation, was identified as NO. NO is a small uncharged radical compound produced by 
oxidation of the terminal guanidino nitrogen of the amino acid L-arginine (figure 2).  The 
process is catalyzed by the constitutive endothelial isoform of NO synthase (eNOS), after 
stimulation by ACh binding to muscarinic receptors. Then, NO enters the smooth muscle cells 
and initiates the signal cascade that ultimately decreases Ca2+ and induces vasorelaxation. 
Besides ACh, shear stress, bradykinin (BK), adenosine tri-phosphate (ATP), ischemia and a 
large number of extra-and intracellular factors may also mediate NO production [56]. 
Inorganic nitrates, such as sodium nitroprusside (SNP), can activate the same effector 
pathway by providing an inorganic source of NO. Their activity is thus not dependent on the 
functional integrity of the vascular endothelium.  
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Figure 2. The nitric oxide signalling pathway. BH4 = tetrahydrobiopterin; Ca++ = calcium ion; cGMP = cyclic 
guanosine monophosphate; eNOS = endothelial nitric oxide synthase; GC = guanylate cyclise; GTP = guanosine 
triphosphate; NADPH = reduced nicotinamide-adenine dinucleotide phosphate; NO = nitric oxide. Figure 
modified from [57].  
 
Once released from the endothelium, NO diffuses through the vascular wall and into the 
smooth muscle cells, where it activates the cytosolic enzyme guanyl cyclase. This enzyme 
activation increases levels of cellular cyclic GMP, which causes relaxation of the vessel wall. 
NO is quite reactive and is broken down within few seconds; thus it has a strictly local effect. 
Higher levels of NO in the smooth muscle cell induce relaxation and are an important cause 
of improved endothelial function after exercise training [58]. Decreased bioavailability of NO 
is characteristic for endothelial dysfunction, and contribute to hypertension, atherogenesis, 
and the progression of cardiovascular disease.  
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Prevention of decompression injury 
 
To protect the diver from a critical level of supersaturation, different decompression tables 
have been evolved. The first decompression table was developed by Haldane in 1908, and all 
common decompression schedules in use since have been based on the model that the body 
could tolerate a two-to-one reduction in ambient pressure without symptoms [59]. In animals, 
a fast decompression rate has been demonstrated to be a determining factor for DCS [60] [61]. 
 
Other methods to prevent injury to the diver, besides the development of decompression 
tables, have involved O2 before exposure [62], exercise before exposure [63] [64] [65] [66], 
medication in fluid balance and surface tension [67] [68] and use of drugs before exposure 
[69] [70]. After a single bout of high-intensity aerobic exercise 20 h before a dive bubble 
formation was suppressed preventing death in rats. The beneficial effect was explained by the 
possibility that there was an increase in vascular endothelial NO bioavailability after the 
exercise. However, it has been shown that bubble production is increased by NO blockage in 
sedentary but not in exercised rats, indicating that the exercise effect may be mediated by 
other factors than NO [69]. Our laboratory have previously shown that even low bubble loads 
lead to endothelial dysfunction [14], and have shown the relationship between exercise and 
endothelial function [58]. Exercise is also one of the treatments recommended for chronic 
endothelial dysfunction, which indicates further the importance of physically fitness in diving. 
As younger, slimmer, or aerobically fitter divers has been shown to produce less bubbles 
compared with older, fatter, or poorly physically fit divers [71], the idea of personalization of 
decompression tables and computers has evolved. As Moon et al.[72] wrote: “the probabilistic 
models on which tables and computers are based should reflect the individual reality of the 
divers, to enable them to conduct their dives in accordance with their individual 
characteristics”.  
 
Heat shock proteins (HSP) is present in most cells, and play a key role in normal cellular 
homeostasis and cell protection from damage in response to stress-stimuli. Endurance 
exercise is an example of a stressor which increases the expression of HSP70 [73]. Increased 
expression of HSP70 and following protection of rats from air embolism-induced lung injury 
has been found with heat shock pre-treatment before diving [74]. Thus, exercise-induced 
HSP70 production seems to affect the bubble formation after diving with a different 
mechanism than the NO pathway [63].  
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Biochemical agents are also of interest with regards to reactive oxygen and nitrogen species 
(ROS and NOS). Oxidative stress in the vessel wall is associated with the generation of 
ROS/NOS by several oxidases. ROS reduces the local NO by hyperoxic vasoconstriction and 
impairment of NO dependent vasodilatation [75]. A variety of antioxidants have proved to be 
protective on the pulmonary endothelial function after a cardiopulmonary bypass [76] and on 
acute endothelial dysfunction after diving [77] .   
 
Another attractive candidate has been the use of fluorocarbons. These compounds are  
characterized by a high gas dissolving capacity (O2, CO2, inert gas), low viscosity and 
chemical and biological inertness [78]. The O2 solubility of fluorocarbons is 20 to 25 times 
greater than that of blood plasma [79]. Thus, intravenous administration of these agents may 
increase tissue O2 delivery. Also, because of higher diffusion gradients, the effect of the 
fluorocarbons upon bubbles would be a reduction in bubble size. Reduced mortality in gas 
embolism [80] reduced brain infarct size [81] and improved cardiovascular function after air 
embolization [82] have been found in animals, but the efficiency of perfluorocarbons in 
humans is still to be proved [83].  
 
Treatment of DCS in remote areas 
 
The first described treatment of decompression sickness was by Pol and Wattelle in 1841. 
They observed that caisson workers were relieved by symptoms if they were re-enterd into the 
high-pressure environment. But it was not until 1924 in the US Navy Diving Manual that 
recompression treatment was recommended for divers [83]. Several years later the use of O2 
under pressure became recognized. Today, there are different treatment tables depending on 
the severity of the decompression accident, ranging from tables to use when one 
suspects/diagnose arterial gas embolism, to treatment-tables for saturation accidents. All these 
treatments require a hyperbaric chamber. But, in situations where several hours will elapse 
before the diver(s) can be brought to a recompression facility, treatment of DCS still remains 
a significant problem. A large number of the divers treated have significant sequelae with 
signs and symptoms from the CNS [84] [45]. 
 
Today much recreational diving takes place at remote locations where transportation of an 
injured diver to a recompression chamber might take several hours. Although there are 
arguments whether the time to treatment is of importance or not [85] [86] [87] [88], it appears 
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that with longer delays (6 h or more), further delay does not affect the outcome of the 
treatment significantly [86]. Thus, to achieve the best possible outcome the diver should be 
treated promptly, and longer delay than a few hours should in any case not be allowed. In 
view of this development there has been renewed interest regarding in-water recompression 
treatments.  
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METHODS 
 
Animal research guidelines 
 
All experimental procedures conformed to the European Convention for the Protection of 
Vertebrate Animals Used for Experimental and other Scientific Purposes, and all protocols 
were approved by the Norwegian Council for Animal Research.  
 
The animals 
 
In the present studies, pigs (Sus scrofa) were used as experimental animals. The choice of 
animal model was based on the experimental expertise in the Baromedical and Environmetal 
Physiology group, which have established and used this model in several previous studies 
[89], [33], [61], [19], [90], [91].   
 
In paper II male pigs of the strain Norwegian Landrace (Sus scrofa domestica) were used. In 
paper I and III both sexes of a more common bred pig called hybrid were the choice of 
experimental animal. All pigs weighed between 18 and 22 kg when arriving at the housing 
facilities at St Olavs Hospital in Trondheim, and were 8–12 weeks old. The pigs were 
acclimatized for one week before start of any of the experiments and were under the 
supervision of a veterinarian. They received a pellet diet once a day and had free access to 
water.  
 
Surgery 
 
Before the experiments in all of the three papers, the animals were fasted for 16 h with free 
access to water. On the day of the experiment, they received premedication with 10 ml 
Stresnil (Azaperon, Janssen-Cilag Pharma, Wien) and 2 ml Stesolid (Diazepam 5 mg · kg-1, 
Dumex-Alpharma AS, Copenhagen) i.m. After 20 min, atropinesulfate (Atropin, 1 mg i.v.; 
Nycomed Pharma) was given via an ear vein. Anaesthesia was induced by thiopental sodium 
(5 mg · kg-1 Pentothal Natrium, Abbott Scandinavia) and ketamine (20 mg · kg-1 Ketalar; 
Pfizer). The anaesthesia was maintained by a continuous i.v. infusion of ketamine in 0.9% 
NaCl (30 mg · kg-1 · h-1) together with bolus doses of α-chloralose in 0.9% NaCl (10-15 mg · 
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kg-1 injected i.v.; 0.25% solution). A tracheotomy was performed to allow the pigs to breathe 
spontaneously through an endotracheal tube. Throughout the experiments, the pigs were in a 
supine position. The depth of anaesthesia was maintained at an even level, as judged by 
clinical observation and the various measured physiological variables as outlined in each of 
the papers.  
 
In all three papers, polyethylene catheters were introduced both in the left jugular vein and in 
the abdominal aorta through the right femoral artery for obtaining blood samples and blood 
gas measurements. One of the catheters in the abdominal aorta was dedicated for arterial 
blood pressure measurements. Catheters were also positioned in the right atrium via the right 
jugular vein for measurements of central venous pressure (all three papers) and administration 
of NO or saline (paper II) 
 
Deep body temperature was measured continuously throughout the experiments by a rectal 
thermometer in all three papers, and was adjusted through regulation of the chamber 
temperature by a coil of circulating warm water. Body temperature was kept between 38 and 
39 oC.   
 
The animals were then treated as thoroughly outlined in each of the papers.  
 
Hyperbaric chamber 
 
A dry hyperbaric chamber was used in each of the three studies to simulate the different dives 
and decompressions being performed. The hyperbaric chamber and its instrumentation is 
shown in figure 3. The chamber has a volume of 300 L, and is pressurized with air. Inside the 
chamber the pig breaths spontaneously using a closed system isolated from the air used to 
increase the pressure. The different pressure profiles and breathing gases are described in 
more detail in the papers.  
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Figure 3. Schematic figure of the pressure chamber and its subsystems. TEE-probe, transesophaegal 
echocardiographic probe.  
 
Bubble detection 
 
A 5.0 MHz transesophageal echocardiographic transducer was inserted in the esophagus and 
positioned to obtain a simultaneous two-dimensional view of the pulmonary artery and the 
aorta. The transducer was connected to an ultrasonic scanner (CFM 750; Vingmed Sound, 
Horten, Norway), and data was continuously transferred to a Macintosh computer which 
analysed the amount of bubbles detected in the pulmonary artery. From the images, the 
amount of bubbles in the right ventricular outflow tract is given as number of bubbles per 
square centimetre (bubbles · cm-2) as described by Eftedal & Brubakk [92]. Simultaneous to 
the automatic counting system by the computer, the amount of bubbles seen in the pulmonary 
artery was graded on a scale between 0 and 5 according to a grading scale given the following 
definition: 0 = no bubbles; 1 = an occational bubble; 2 = at least one bubble every 4th 
heartcycle; 3 = at least 1 bubble in each heart cycle; 4 = continous bubbling, at least one 
bubble/cm2 in all frames; 5 = bubbles causing frequent distortion of image (“white-out”) [93].   
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Blood gas measurements 
 
Both arterial and venous blood was sampled during each experiment. In paper I and II the 
blood samples were analyzed on an ABL 330 blood gas analyzer (Radiometer, Copenhagen, 
Denmark). In paper III the blood samples were analysed on an ABL 700 blood gas analyzer 
(Bergman Diagnostika, Lillestrøm, Norway).  
 
Endothelial tension measurements 
 
An isolated organ bath model was used to study the local pharmacological mechanisms and 
signalling pathways in isolated vessels and allows the exclusion of any influence from higher 
regulatory systems. The equipment for the tension measurements were identical to the system 
previously developed and described [94]. Two Vessel Tension Measuring Instruments, each 
containing four channels with four separate buffer containers, were connected in series. A 
total of eight vessel segments could therefore be tested at the same time.  
 
The pulmonary artery from the right lung and the right carotid artery were carefully dissected 
and stored in oxygenated (5% CO2; 95% O2) sodium-Krebs buffer solution for a maximum of 
24 h. The vessels were cut into cylindrical segments and mounted in the isolated organ bath. 
The contractile capacity of each vessel segment was examined by exposure to a potassium-
rich K-krebs buffer solution.  
 
Norepinephrine in cumulative doses was used to precontract the segments until they had 
reached a stable level. The relaxation response was tested with cumulative doses of ACh (10-9 
– 10-4M) and BK (10-11- 10-6 M) and the response was depending on the degree of damage to 
the endothelial layer. The relaxation response IMAX is defined as the maximal dilatory 
response induced by an agonist expressed as a percentage of the precontraction induced by a 
precontracting agent. TMAX is defined as the maximum level of stabilised relaxation response. 
In addition, -pED50 is defined as the concentration of the agonist that leads to 50% of the 
relaxation response (IMAX or TMAX). The functionality of the vascular smooth muscle cells was 
tested with SNP, which are endothelial independent. The vessels that did not respond had a 
functional failure in the vascular smooth muscle cells, and these segments were rejected.  
 
Tension measurements were performed in paper III, and are described in further detail there.  
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Statistics 
 
All statistical analyses were performed using SPSS 13.0.  In paper I, II and III a student t-test 
for independent samples was used to compare the number of bubbles during the observation 
period. In paper II Mann-Whitney U test was used to evaluate differences in the blood-gases, 
and in paper III the Mann-Whitney U test was used to evaluate the tension data. The choice of 
a non-parametric test was based on the low number of experimental animals.  
 
All data in the three papers have been presented as mean with standard deviation as outlined 
in each of the three papers. The level of significance was set to P<0.05.  
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 SUMMARY OF PAPERS 
 
Paper I 
 
Møllerløkken A, Gutvik C, Berge VJ, Jørgensen A, Løset A, Brubakk AO. Recompression 
during decompression and effects on bubble formation in the pig. Aviat Space Environ Med 
78(6): 557-560, 2007. 
 
A modified USN standard air dive profile and a dive profile which had a 5 min recompression 
of 50 kPa at the end of each of the three last decompression stops before ascending to the next 
stop depth was compared with regard to bubble formation during and after decompression. 
Bubbles were detected with an ultrasonic transducer, and counted by an automated 
programme. All animals which underwent the modified USN standard air dive profile 
developed bubbles, whereas only one animal in the recompressed group had detectable 
bubbles. The results can not be explained by any traditional supersaturation based model of 
decompression, since they would have predicted the opposite result. In stead, we suggest that 
a gas-phase model of decompression would be more suitable for describing our findings.  
 
Paper II 
 
Møllerløkken A, Berge VJ, Jørgensen A, Wisløff U and Brubakk AO. Effect of a short-acting 
NO donor on bubble formation from a saturation dive in pigs. J Appl Physiol 101: 1541-1545, 
2006.  
 
Our laboratory has previously shown that NO is involved in the protection against vascular 
gas bubble formation. In this paper we investigated the effect of a short acting NO donor 
given immediately before start of decompression from saturation on vascular gas bubble 
formation in pigs. This study was the first to use large animals to demonstrate the protective 
effects of nitrates with regard to decompression effects. The bubbles were detected by the 
means of ultrasound, and counted continuously by an automated computer programme. 
Significant decrease in the amount of vascular gas bubbles were found in the pigs receiving 
NO immediately before decompression started compared with a control group. No significant 
differences were found in blood pressure, although a higher heart rate was observed in the 
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experimental group. The study clearly demonstrates that NO is exceptionally effective in 
reducing bubble formation also from saturation. 
 
Paper III 
 
Møllerløkken A, Nossum V, Hovin W, Gennser M, Brubakk AO. Recompression with 
oxygen to160 kPa eliminates vascular gas bubbles, but does not prevent endothelial damage. 
Europ J Underwater Hyperbaric Med 8(1&2): 11–16, 2007. 
 
The effect on bubble formation of recompression to 160 kPa with oxygen 60 min after a 
strenuous dive was investigated in this study. The study was initiated in order to use our 
knowledge of bubble-detection and investigate the possibilities for remote diving sites to 
perform simple first aid if the proper treatment facilities are too far away, and to do so with as 
little risk for oxygen seizures as possible.  60 min after the dive, the experimental group were 
recompressed to 160 kPa breathing oxygen for additional 60 min, while the control group 
remained at the surface breathing air. The recompression did remove the vascular gas bubbles, 
but did not prevent an impaired endothelial response. We speculate that the 60 min before 
initiating treatment is too long to avoid bubble induced damage to the endothelium.  
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RESULTS AND DISCUSSION 
 
Reduction of vascular bubbles was achieved by short recompressions at the end of the 
standard decompression stops from an air dive in pigs, indicating that a gas phase model 
describes most accurately the decompression process (Paper I). Further, injection of a short 
acting NO donor 30 min before start of decompression from a sub-saturation dive was found 
to give a significant reduction of vascular gas bubbles detected in the right ventricular outflow 
tract in pigs (Paper II). In paper III the effectiveness of a simulated in-water recompression to 
160 kPa with oxygen showed rapid removal of vascular gas bubbles detected after the dive, 
but did not prevent an impaired endothelial response.  
 
Gas bubbles and validation of decompression procedures 
 
One of the main problems related to the development of new and improved decompression 
procedures and the validation of decompression profiles, is the large variability between 
individuals, both in DCS incidence and bubble formation. Even in animal experiments, where 
physiological variables are tightly controlled, there is a considerable and significant difference 
in response between individuals. The same dive can produce few or many bubbles, and the 
response to bubbles differ as well. Further, studies have shown that numerous professional 
divers have suffered DCS in spite of using accepted procedures. These studies concluded that 
there probably is a considerable underreporting of clinical symptoms related to 
decompression [95] [96]. 
 
A workshop in 1989 at Undersea and Hyperbaric Medicine Society (UHMS)[97] addressed 
the validation of decompression procedures. They concluded that procedures should be 
validated primarily by extensive, dedicated laboratory testing before putting into the field for 
“operational evaluation”. Based on the assumption that procedures that give no symptoms of 
DCS will have no effect upon the health of the individual, and that if mild DCS can be 
prevented, than more serious changes will not be found [93].  The endpoint for testing has 
been the occurrence of DCS or not.  
 
Modern decompression procedures have a low incidence of clinical DCS; around 0,3-1%. 
Proving the safety of the dives using DCS as an endpoint with a reasonable degree of 
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confidence will require many more dives than are normally feasible. With the binominal 
distribution more than 300 exposures on the same procedure with no incidents are needed to 
confirm a DCS risk below 1% with a 95% confidence interval. For recreational diving, the 
incidence should be considerably lower than this, requiring even more testing before the 
procedure can be put into practical use. Also, the diagnosis of DCS can be quite subjective. 
Using circulating gas bubbles as an indicator for the safety of the dive provides more 
information than DCS itself in assisting the severity of a dive profile. Hence, the main reason 
for detecting vascular gas bubbles is to obtain comparative information, post-dive, to assist in 
determining whether or not a table or profile is safe or hazardous by determining the quantity 
and duration of bubbles resulting from that profile [6]. Recent work by Eftedal et al.[98] 
combines the information obtained from the detection of vascular gas bubbles with previous 
knowledge and assumptions, and points the way for validating decompression procedures by 
using smaller sample sizes then one have been obliged to do historically.  
 
The influence of gas bubbles on decompression models 
 
Different decompression models all seek to give the best control of bubble growth, but 
present decompression theory appears seriously deficient in its treatment of gas exchange and 
bubble growth. Hence, decompression models that incorporate even the most advanced of 
these treatments remain incomplete. When used to prescribe decompression procedures, they 
all allow some degree of bubble formation in order to reach an acceptable balance between 
productive bottom time, decompression obligation and risk of DCS. But they inevitably focus 
on the control of gas supersaturation and bubble formation per se, and fail to consider the 
effect of bubbles after they have diminished or resolved.  
 
Haldane put up a ratio of supersaturation which could be tolerated without bubble formation 
after ascent to the surface or the next decompression stop, and divided the body into five 
different tissues with distinct properties for gas elimination [2]. Being multi-tissue-models, 
Haldane models rely on inert gas remaining dissolved in the blood and the body tissues during 
decompression. The typical staged decompression profile produced by a Haldanian model 
utilizes relatively shallow stops in order to maximize the off-gassing gradient for the 
presumably dissolved inert gas, and do not take into account any free phase of gas; that is, do 
not account for the effect of bubbles. It has been shown that elimination of nitrogen from a 
bubble is slower than the elimination of nitrogen dissolved in the tissue [99] [2].  
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Bubble models are designed to cater for free-phase gas as well as dissolved gas. In stead of 
maximum tensions that Haldanian models use, bubble models use critical gradients to 
minimize the bubble growth by keeping the tension of inert gas within the bubbles equal to, or 
higher than, the tissue tension. In this way, inert gas will diffuse out from, rather than into, the 
bubbles. The bubble size will hence be reduced. The most efficient elimination of free-phase 
gas is at greater ambient pressures as this is where the internal pressures of the bubbles are 
highest and, hence, the driving force of gas from the bubble is greatest. By utilizing slow 
ascent rates and deeper decompression stops, bubble models aim to eliminate or minimize any 
differences in ambient pressure and total tissue tension (supersaturation) and thereby control 
the volume of free-phase gas within the body.  
 
There are two mechanisms which affects the exchange of inert and metabolic gas between 
tissue and blood, and that is perfusion and diffusion. Perfusion denotes the blood flow rate in 
simplest terms, while diffusion refers to the gas penetration rate in tissue, or across tissue-
blood boundaries. Each mechanism has a characteristic rate constant for the process. The 
smallest rate constant limits the gas exchange process. In the past, model distinction was 
made on the basis of perfusion or diffusion limited gas exchange. Supersaturation is usually 
regarded as the driving force leading to gas leaving solution and forming bubbles [4], and the 
rate of growth of these bubbles will be influenced by their initial size. According to the 
LaPlace equation, the gas tension inside a bubble is inversely proportional to bubble size. 
That is, if the gas tensions in the fluid (e.g. blood) exceed the gas tension inside the bubble, 
the bubble will grow. Thus, the larger the bubble, the larger the gradient for bubble growth 
and consequently the smaller the gradient for bubble decay. Paper I shows that having a 
model taking both bubble size reduction and surface tension into account might explain how a 
recompression phase during the decompression would decrease the number of detectable 
vascular gas bubbles. During a recompression, the bubble size will be reduced, and inert gas 
tension starts to increase with the consequence that gas will diffuse out of the bubble. Gas 
diffusing out of the bubble will increase gas tension in the tissue, which again reduces the 
uptake of gas. Furthermore, as gas tension in the tissues is low because of the effect of 
bubbles [100], an increase in gas tension will increase the elimination of gas. Hence, even if 
bubbles increase in size on subsequent ascent, they will do so at a slower rate and from a 
smaller size than before. 
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Decompression is a trade-off between dissolved gas build-up and free phase growth, and the 
goal of decompression theory is to prevent or control the incidence of DCS, keeping 
incidence and severity within acceptable limits. One has to incorporate both in order to have a 
decompression theory which can reflect the many processes taking place in the organism 
when experiencing changes in the ambient pressure.  
 
Vascular gas bubbles, NO and endothelial function 
 
NO is produced by endothelial cells as a response to an increase in shear stress caused by 
increased blood flow [101], and is the most important vasodilator released by endothelial cells 
[55]. Once released from the endothelium, NO diffuses through the vascular wall and into the 
smooth muscle cells, where it activates the cytosolic enzyme guanyl cyclase. This enzyme 
activation increases levels of cellular cyclic GMP, which causes relaxation of the vessel wall. 
In a previous study in rats, our laboratory demonstrated that NO given immediately before a 
45 min air dive effectively reduced bubble formation [70]. Due to the fact that NO reduces 
venous tone through a reduction of the preload and hence reduces cardiac output [102] [103], 
part of the effect on bubble formation could have been caused by a reduction in gas uptake. In 
paper II we found a similar positive effect on bubble reduction by NO in a saturation dive, 
which makes the hypothesis of reduced bubble formation by reduced gas uptake less likely.  
 
It is well established that an increase in venous blood flow caused by muscle contraction 
decrease the number of bubbles observed in the venous outflow tract after a dive [104] [105] 
[64].  During diving, tissues will equilibrate with the breathing gas. With an increased blood 
flow, this balance will be achieved more rapidly. A more rapid change in the relationship 
between the breathing gas and the dissolved gas pressure due to an increased blood flow in 
the tissues during decompression could minimize the possible gas bubble formation [105]. An 
alternative explanation on the effect of NO is hence that inert gas washout can be facilitated 
by an increase in venous blood flow. The effect of NO and exercise on vascular gas bubbles 
has also been observed in humans [106] [64]. 
 
The inhibitory effect of NO on bubble formation is not a new finding. Previous animal 
experimental work has been conducted with smaller rodents and explosion-like 
decompressions. Paper II showed two new, unreported findings, the positive effect on larger 
animals, and that NO reduced the amount of vascular gas bubbles in saturation 
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decompression. It is not possible to determine from paper II if an increase in blood flow 
leading to an improved wash-out of nitrogen or changes in endothelial properties that remove 
bubble nuclei are responsible for the reduction in bubble formation; both effects may be of 
importance. Regardless of mechanism, NO seems to be exceptionally efficient in reducing 
bubble formation.  
 
Bubbles are extremely stable on hydrophobic surfaces [107]. Thus, lipid rich micro-domains 
on the surface of the endothelium may have a particular propensity for formation and/or stable 
attachment of bubble nuclei. Invaginations in the vascular wall have been suggested to 
represent such a stabilizing mechanism for bubbles [108]. Brubakk [109] has postulated that 
hydrophobic sites can exist on the surface of the endothelium in the form of caveolae. This 
indicates that the caveolae are attractive sites for the formation of bubble nuclei, since 
reduction in surface tension of hydrophobic membranes have been shown to increase the 
number of stable nuclei [110]. Caveolae are also the location for NO production, further 
supporting the attractiveness of this specific location for bubble formation. It has been 
speculated that NO can reduce the hydrophobicity of the endothelial wall, thus reducing the 
number of nuclei adhering to the surface.  
 
Gas bubbles generated by decompression or directly infused into the venous circulation are 
trapped in the pulmonary capillaries [111] [112], and the pulmonary vascular endothelium is 
one primary site of injury with air embolization [113] [114]. Later studies have confirmed 
these findings [33] [14]. Activation of endothelium in the venous circulation produces EMP 
that can initiate endothelial dysfunction at remote sites [53]. These microparticles have a size 
of a few micrometers and could possibly pass through the lung filter and enter the arterial 
system. Therefore, changes in arterial endothelial function can occur without direct contact 
with the bubbles. The effect of vascular gas bubbles on the endothelium was studied in paper 
III were an impaired endothelial response to ACh, but not to BK, was found in the pulmonary 
artery. The endothelial measurements of the carotid artery did not show any significant 
differences between the groups in our study, although the response to ACh was low here as 
well. The endothelium independent response to SNP seems unaffected by the dive, the 
vascular bubbles and the treatment with recompression and oxygen. This confirms that the 
change in vasoactive response is only related to endothelial function and not to function in the 
vascular smooth muscle layer.  
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Endothelial dysfunction is an early feature of many vascular diseases, resulting in loss of 
normal homoeostatic pathways that act to inhibit disease processes such as inflammation, 
thrombosis and oxidative stress [115] [116]. The positive effect of NO with regards to 
reduction of detectable vascular gas bubbles supports the hypothesis that the endothelium is 
of importance for generation of bubbles, as one critical aspect of normal endothelial function 
is the production of NO by eNOS. Studies have shown that bubbles will reduce the function 
of the endothelium in a dose-dependent manner [33] [14], and circulating endothelial cells 
have been detected in blood in proportion to the severity of DCS [117]. Further, it has been 
shown in vitro that the surface of bubbles can act as a foreign substance and is capable of 
activating the alternative complement pathway [27] [43].  
 
The finding of impaired endothelial response to ACh but not to BK indicates that the 
endothelial response to ACh is affected by different mechanisms. BK is also a potent 
vasodilator that acts by increasing the production of endothelial hyperpolarizing factor 
(EDHF), which again acts on the smooth muscles of the vessels by an NO-independent 
mechanism [118]. In normal endothelium, NO is the main vasodilator, but when the 
endothelium is injured, EDHF production is increased. But, some studies have shown that 
EDHF may have anti-inflammatory properties which reduces the adhesiveness of the 
endothelium similar to the effect of NO [119] which again indicates that the response to 
endothelial injury is quite complex [120].  
 
The treatment used in the experiment (Paper III) did not prevent endothelial damage despite 
removal of the vascular bubbles. This may indicate that the response to ACh was affected by 
breathing 100% O2 under pressure. It is tempting to speculate whether the same response 
would occur if 100% O2 at 100 kPa in the treatment regime was used instead of 160 kPa. A 
previous study at our laboratory showed that recompression to neither 100 kPa breathing 100 
% O2 nor 200 kPa breathing air after a dive to 500 kPa , did not impair the endothelial 
function [89].  In a study by Obad et al. [77], reduction in endothelial function was prevented 
by giving antioxidants, Vitamin E and C, before a dive, indicating that oxygen radicals may 
be involved in developing the endothelial damage seen after a dive. 
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In-water recompression as treatment of DCS 
 
The prevention of DCS through development of decompression tables has been a great 
success, but the disease has not been eliminated. Today, around 50% of those being treated 
are “undeserved hits”, that is people who claim to have followed a specific dive table or 
computer but still ending up for treatment.  The techniques required for treatment of DCS are 
therefore as relevant as ever [87]. In all treatment regimes for DCS the underlying idea is that 
if bubble volume can be reduced quickly after onset of symptoms, it is possible that their 
associated secondary effects can be attenuated [121]. In paper III we used a modified 
emergency procedure for DCS (in-water recompression (IWR)) which consisted of breathing 
100% O2 at a pressure of 160 kPa for 60 min.  
 
The USNavy started development of low pressure oxygen tables in the early 1960´s. The 
initial compression depth was 200 kPa with the diver breathing 100% O2. Depending on the 
patient, the treatment depth was either kept at 200 kPa if the symptoms relieved within 10 
min, otherwise the chamber was pressurized to 280 kPa. Using the 200 kPa table led to a high 
recurrence rate, and the treatment was abandoned, and developing new treatment tables, 
which required an initial recompression to 280 kPa, were started. The most common 
treatment table being used today is the USN Treatment table 6 which recompresses to 280 
kPa [83]. Traditional recompression treatments are conducted in a recompression chamber, 
where the possibilities of nursing the patient are present. 
 
The need for IWR procedures has arisen as a consequence of the increasing diving activity in 
remote areas around the world, as IWR offers the potential of providing treatment when a 
chamber is not available. The nearest treatment facility can be several hours or perhaps days 
away, hence, the in-water procedure might be the only opportunity for adequate treatment 
(Gennsser, personal communication, 2006). Stipp [88] investigated the relationship between 
time to treatment on the outcome of neurological DCS in divers, and showed that after 6-12 h 
there is no further effect of the time till treatment. But the time-window before 6-12 h is 
significant.  
 
The advantages of using oxygen in treatment tables are obvious and include increased 
nitrogen elimination gradients, avoidance of extra nitrogen loads, increasing oxygenation to 
tissues, decreasing treatment depths and exposure time. Recompressions also have the 
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advantage of immediate reduction of the bubble size [122]. In paper III we chose a low 
pressure level of oxygen in order to minimize the hazardous effects of oxygen under pressure. 
The use of oxygen does not only establish an increased partial pressure gradient for inert gas 
from inside to outside a bubble, but also prevents additional uptake of inert gas during the 
recompression phase. The highest ambient pressure at which 100% O2 administration is 
practical is at 300 kPa. Above this pressure, convulsions are likely to occur due to CNS 
oxygen toxicity [87].  The tolerance for CNS oxygen toxicity is dependent on both exercise 
and immersion [123] [124], and as such, the IWR treatment depth should be as shallow as 
possible. Breathing 100% O2 underwater has the potential to be a highly effective means of 
preventing emergence of DCS after a significant omitted decompression. But the strategy 
requires proper training and equipment, and is most often invoked by technical divers for 
emergency in-water oxygen recompression of a diver who has actually developed DCS. The 
major risk is oxygen toxicity manifest as a seizure. Unless the diver is wearing a full-face 
mask when this occurs, the very likely result is drowning [125]. The suggested initial 
compression depth is 190 kPa, but even at this pressure there is some risk of oxygen toxicity. 
Hence, reducing the treatment pressure will reduce the risk of getting oxygen seizures and 
thus increase the safety of the diver. Paper III shows that vascular gas bubbles can be 
eliminated with low pressure recompression, but the optimal time interval between a 
decompression accident and start of treatment remains to be investigated.  
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METHODOLOGICAL CONSIDERATIONS 
 
Experimental procedure 
 
The pig was used as experimental animal throughout this thesis, since such a model for 
decompression studies was already established at our research group. The pig is generally 
considered a good model for human physiology, but our model does have improvement 
potential. The anaesthetics being used is the main drawback of our model. Since we work 
with spontaneously breathing pigs, the choice of anaesthesia has been ketamine, with bolus 
injection of the muscle relaxant alpha-chloralose.  Ketamine is difficult to work with, since 
the pig’s response to the drug is very variable. Some experimental animals fall asleep at once, 
but others can tolerate large amounts of ketamine before any surgery can be performed. The 
supine position of the experimental animal is also a source of variability in our experiments. 
Observations of both hyperventilation and that some of the lungs show congestion, indicate 
that in some situations, the ventilation of the lungs may be inadequate. However, the fact that 
animals have been kept alive on this anaesthesia for over 16 hours with no ill effect 
(unpublished observations) and that our research group have published a number of papers 
where this specific animal model have been used [19]  [90] [91] [61] [33], indicate that this 
might be a minor problem.  
 
Detection of gas bubbles by ultrasound 
 
The use of ultrasound to detect intravascular gas bubbles is based on the combination of the 
non-invasive and real-time nature of ultrasonic systems combined with the acoustic properties 
of gas bubbles in blood. The most common detection method is the use of ultrasonic Doppler 
equipment which transforms reflections from moving gas bubbles into audible sound. The 
audible signal is then estimated by means of a non-linear grading system, and the Spencer and 
the Kisman-Masurel codes are the most commonly used [93]. 
  
In resent years, ultrasonic imaging systems have become more available and have been shown 
to be well suited for detection of intravascular gas bubbles [126]. As the ultrasonic Doppler 
method requires extensive training both with regards to the monitoring itself and to the 
interpretation of the Doppler signals [93], the use of ultrasound imaging techniques requires 
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far less training, even by persons with little previous experience [126]. It has been shown that 
the bubble grades from the different detection methods can be directly compared at rest [127].  
 
The venous blood is the easiest place to detect bubbles. The pulmonary artery or the right 
ventricle of the heart are the most commonly used locations for detection of intravascular gas 
bubbles both with Doppler (precordical detection) and with imaging systems (both 
precordical and transesophageal echocardiographic measurements). All the venous blood is 
transported through this area before it is pumped through the lungs. Experiments suggest that 
gas nuclei are not present in the blood stream and that bubbles observed with ultrasonic 
techniques can originate from tissues and/or microcapillaries and migrate into the circulation 
[128]. Gas nuclei have been found in the outermost layer of the skin that did cavitate when 
they where irradiated by ultrasound [129]. The only other tissues in which bubbles are 
routinely observed are the joints, including the spinal cord. These are the structures most 
frequently affected by DCS. Tissues in which bubbles do not form at physiologic 
supersaturations would be expected to be affected only by vascular bubbles that originate at 
other sites, i.e., lungs, brain [130].  
 
Ultrasonic bubble detection has its limitations as a predictive tool for bubble-induced illness. 
Present technology is only practical for bubble detection in flowing blood; bubbles are usually 
only detected on the venous side of the circulation, from which most are removed by the 
pulmonary capillaries. Nevertheless the appearance of many venous bubbles can overwhelm 
the filtration abilities of the pulmonary capillary network and have been shown to correlate 
with clinical DCS in humans [130] [131]. A method utilizing high resolution imaging was 
developed by Daniels et al [132] which enabled detection of both stationary and moving 
bubbles. Unfortunately, the system has not been developed further, and today there are no 
available ultrasonic detection methods for stationary bubbles. Since there seems to be no clear 
relationship between vascular gas bubbles and DCS, the detection of bubbles by ultrasound 
can not be used as diagnostic criteria for DCS. However, there is evidence today that 
intravascular bubbles cause subclinical damage that may have long-term effects; thus 
quantification of bubbles in the venous system can offer a graded measure of decompression 
safety [93] [98] [131].   
 
The use of a Transesophageal Echocardiographic (TEE) probe was the main detection method 
used during the whole study, and this method has been used extensively in our research 
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group. The probe gives a good view of both the right pulmonary artery and the aorta and is 
more or less perfect for the studies we have performed. Most of the time it was easy to 
position the probe, but in some pigs echoes from the lungs disturbed the image and made it 
more difficult to interpret. Although ultrasonic images seem to have a lower threshold for 
detection of gas bubbles than the Doppler method [93], only a two-dimensional slice of the 
pulmonary artery or the aorta is available for detection and quantification of gas bubbles. In 
addition, it is not verified exactly how small the gas bubbles can be, and still be detected. The 
threshold is both dependent on the frequency of the transducer and the depth from the probe at 
which bubbles are to be detected [133]. The sensitivity of our detection method is high, but 
the specificity is low. For our research on decompression and vascular bubbles, this is one of 
the main areas where future ultrasonic probes with higher frequencies can bring about more 
insights and knowledge.  
 
CONCLUSION AND FUTURE PERSPECTIVES 
 
The present work has demonstrated that the amount of vascular gas bubbles detected during 
and after decompression can be affected by changing the decompression profile in a way that 
can not be explained by traditional decompression models, and we suggest that a gas phase 
model is needed to describe the decompression.  Further, we reduced the amount of vascular 
gas bubbles by injecting a short acting NO donor before start of decompression from 
saturation, showing for the first time that nitrates have a protective effect in larger animals. 
And finally we showed that the time gap between a decompression incident and a chosen 
treatment for 60 min was too long to avoid impaired endothelial function despite removal of 
gas bubbles in the circulation, indicating that treatment should be initiated as fast as possible.  
 
The incidence of DCS has been reduced over the last 40 years, but the relative number of 
incidents of DCS involving the CNS has increased. While supersaturation has been a major 
focus in nearly all research within this field, the future research will focus more on 
biochemical pathways to uncover the secrets of the bubbles, both in their generation and their 
pathophysiological effect.  
 
The use of biochemical agents to modify decompression and to reduce the risk of bubble 
formation is important, despites the very fact that the preventive use of drugs in commercial 
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diving is forbidden by international labour laws. But in situations where one is forced to 
decompress more quickly than an established decompression table would allow, such a 
preventive drug could be useful. An example of such a scenario is with a disabled submarine. 
Two specific points have been made to the ameliorative effect of nitrates on bubble formation 
which needs to be investigated. One is the fact that nitrates inhibit platelet aggregation and 
leukocyte adhesion, which has been suggested as sites for bubble formation [134]. The other 
point is that it remains to be investigated whether the effect of nitrates is just a haemodynamic 
effect or not.  
 
Bubbles need something to grow from; de novo formation is considered unrealistic in any 
human decompression situation. In blood vessels, nuclei are probably attached to the blood 
vessels endothelium where they grow into bubbles that are dislodged into the blood stream. 
Thus, any process that influences the surface properties of the endothelium may affect bubble 
formation in the vascular system. In the endothelial cells, there are specific structures which 
need future attention, and that are the caveolae. Caveolae normally function to facilitate the 
uptake of fluid by the cell. In the process of pinocytosis, the caveolae close and pinch off to 
form pinosomes, little fluid-filled bubbles within the cell. Endothelial NO synthase (eNOS) 
has been localized to caveolae, and Linder et al. [135] have shown that molecules in the NO-
signaling pathway such as soluble guanylyl cyclase, cAMP-dependent protein kinase and 
cGMP-dependent protein kinase are also co-localized in caveolae. Because exogenous NO 
reduces bubble formation, it is possible that bubble nuclei are also co-localized in the 
caveolae with eNOS and NO-related molecules. Using eNOS knock-out mice should be 
investigated for such relationships in the future.  
 
With the development in ultrasonic imaging computers, it will be possible to look for, in vivo, 
attractive sites for both generation of and growth of bubbles as well as determining the size of 
the bubbles. With the aid of contrast agents and new detection methods with ultrasound, 
stationary gas bubbles will probably become detectable again.   
 
Further studies on emergency treatment-situations (recompression treatments) should also be 
conducted. Based on our findings in paper III, it is obvious that by waiting 60 min before 
initiating treatment, the endothelium is damaged despites the following removal of vascular 
bubbles by recompression and oxygen. Today the recommended treatment is 190 kPa 
breathing oxygen, and it would be too early to make any recommendations to change that 
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procedure based on our study presented here. Future studies with IWR should investigate the 
immediate effect of a recompression, both to 190 kPa and to 160 kPa, keeping the effects of 
oxygen toxicity in their mind.  
 
There is evidence that the occurrence of at least some forms of DCS is not entirely consistent 
with purely physical processes. As an arguable result, inability to predict or control DCS 
severity is perhaps the most glaring deficiency of modern DCS prevention algorithms [9]. 
This is largely due to the relatively mild nature of the DCS cases that are in the data available 
for model calibration. Because purposeful experimentation to severe outcomes is impossible 
with humans, expansion of model capability to cover more severe cases will require an 
improved understanding of how changes in bubble location, size and profusion translate into 
changes in DCS severity. Then we will have an ability to quantitatively scale results from 
animal experiments to humans. 
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